4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-22-012325
Director bought 175,132 shares at an average $1.47 ($256,970)
From the SEC's structured data for this filing
Trades in this filing
HILZINGER KURT J · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-22 | Purchase : show line 1 in the form | +95,597 | $1.49 | $142,440 | 118,714 | D |
| 2022-02-23 | Purchase : show line 2 in the form | +79,535 | $1.44 | $114,530 | 198,249 | D |
| Open-market purchases · 175,132 sh · avg $1.47 · $256,970 | ||||||
Loading xslF345X03/doc4.xml…